New antibiotic could shield blood cancer patients from deadly infections

This study is for people with blood cancers like leukemia who are getting chemotherapy or a stem cell transplant, which can cause very low white blood cell counts (neutropenia) for over a week. The goal is to see if the antibiotic eravacycline can prevent serious bacterial infections during this vulnerable time. About 55 participants will receive the drug, and researchers will track how many get breakthrough infections and any side effects.